Stonepine Capital Management LLC acquired a new position in Aytu BioPharma, Inc. (NASDAQ:AYTU – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 472,369 shares of the company’s stock, valued at approximately $756,000. Aytu BioPharma accounts for approximately 0.3% of […]
Aytu BioPharma (NASDAQ:AYTU – Get Free Report) and Hero Technologies (OTCMKTS:HENC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, profitability and analyst recommendations. Valuation & Earnings This table compares Aytu […]
Aytu BioPharma, Inc. (NASDAQ:AYTU – Get Free Report) was the target of a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 352,800 shares, an increase of 12.0% from the August 15th total of 314,900 shares. Based on an average trading volume of 39,500 shares, […]
Aytu BioPharma, Inc. (NASDAQ:AYTU – Get Free Report) traded down 4.5% on Thursday . The company traded as low as $1.70 and last traded at $1.70. 11,426 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 67,743 shares. The stock had previously closed at $1.78. Analysts Set New […]
Maxim Group initiated coverage on shares of Aytu BioPharma (NASDAQ:AYTU – Free Report) in a research note released on Wednesday, Marketbeat.com reports. The brokerage issued a buy rating and a $5.00 price target on the stock. Aytu BioPharma Stock Down 2.3 % NASDAQ:AYTU opened at $1.73 on Wednesday. The firm’s 50 day simple moving average […]